Here's Why Cassava Sciences Stock Could Make a Comeback

03:37pm, Friday, 01'st Apr 2022 The Motley Fool
It helps to have plenty of cold, hard cash.
It helps to have plenty of cold, hard cash.
SAVA stock is volatile but worthwhile after opinion shifts in its favor. Remember, it has a blockbuster Alzheimer's drug nearing launch.

Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know

10:00pm, Friday, 25'th Mar 2022 Zacks Investment Research
Cassava Sciences, Inc. (SAVA) closed at $40.17 in the latest trading session, marking a -1.62% move from the prior day.

Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know

09:50pm, Friday, 18'th Mar 2022 Zacks Investment Research
In the latest trading session, Cassava Sciences, Inc. (SAVA) closed at $39.08, marking a -0.13% move from the previous day.
If you can stomach the risk and have experience investing in clinical stage biotech plays, SAVA stock remains an interesting situation. After its recent weakness, you may find now to be the right time

Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know

11:00pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $37.65, moving +0.51% from the previous trading session.

Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know

10:50pm, Friday, 04'th Mar 2022 Zacks Investment Research
In the latest trading session, Cassava Sciences, Inc. (SAVA) closed at $37.31, marking a +0.54% move from the previous day.
In the latest trading session, Cassava Sciences, Inc. (SAVA) closed at $37.31, marking a +0.54% move from the previous day.

Implied Volatility Surging for Cassava Sciences (SAVA) Stock Options

01:48pm, Friday, 04'th Mar 2022 Zacks Investment Research
Investors need to pay close attention to Cassava Sciences (SAVA) stock based on the movements in the options market lately.
SAVA stock is driven by updates on clinical Phase 3 trials and lots of irrationality. Meanwhile, an FDA approval may take quite some time.

Cassava Sciences, Inc. (SAVA) Gains But Lags Market: What You Should Know

10:50pm, Friday, 25'th Feb 2022 Zacks Investment Research
Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $42.51, moving +1.19% from the previous trading session.
Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $42.51, moving +1.19% from the previous trading session.

Why Cassava Sciences Is Still a High-Risk Play

01:17pm, Friday, 25'th Feb 2022
As it's not set in stone that Cassava Sciences will be able to bring simulfilam to market, you should approach SAVA stock cautiously. The post Why Cassava Sciences Is Still a High-Risk Play appeared f

Cassava Sciences, Inc. (SAVA) Gains But Lags Market: What You Should Know

10:50pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $49.22, moving +1.07% from the previous trading session.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE